EdiShorts

UPSC Prelims 2023 CSAT Q63 · Comprehension

Year2023
PaperCSAT
QuestionQ63
SubjectComprehension

Pharmaceutical patents grant protection to the patentee for the duration of the patent term. The patentees enjoy the liberty to determine the prices of medicines, which is time-limited to the period of monopoly, but could be unaffordable to the public. Such patent protection offered to the patentees is believed to benefit the public over the longer term through innovations and research and development (R&D), although it comes at a cost, in the nature of higher prices for the patented medicine. The patent regime and price protection — through a legally validated high price for the medicine during the currency of the patent — provide the patentee with a legitimate mechanism to get returns on the costs incurred in innovation and research.

Based on the above passage, the following assumptions have been made :
1. Patent protection given to patentees puts a huge burden on public's purchasing power in accessing patented medicines.
2. Dependence on other countries for pharmaceutical products is a huge burden for developing and poor countries.
3. Providing medicines to the public at affordable prices is a key goal during the public health policy design in many countries.
4. Governments need to find an appropriate balance between the rights of patentees and the requirements of the patients.
Which of the above assumptions are valid ?

  1. a1 and 2
  2. b1 and 4
  3. c3 and 4
  4. d2 and 3
Show answer & explanationHide answer
Correct answer(b) 1 and 4

Statement 1 directly follows from the passage's mention of high costs burdening public purchasing power, and Statement 4 is a valid underlying implication regarding balancing patentee rights with patient needs.

Statement-by-statement analysis

✓ Statement 1
  • The passage explicitly states that patent protection allows high legally validated prices that could be unaffordable to the public.
  • This directly supports the assumption that patent protection burdens the purchasing power of the public.
✗ Statement 2
  • The passage does not mention dependence on other countries or the economic status of developing and poor nations.
  • This statement relies on external facts not assumed or stated within the passage boundaries.
✗ Statement 3
  • The passage focuses on the mechanics of patent protection and R&D cost recovery.
  • It does not discuss the explicit goals of public health policy design across various countries.
✓ Statement 4
  • The text presents two contrasting needs: returns on R&D for patentees and affordability for patients.
  • The necessity for governments to find a balance between these two competing interests is a valid underlying assumption of the discussion.

Concept to know

  • CSAT comprehension assumption questions require identifying unstated premises or direct logical implications required for the author's premise to hold.
  • Strictly limit analysis to the information provided in the passage without bringing in outside general knowledge.
  • Identify key trade-offs highlighted in the passage, such as innovation incentives versus consumer affordability.
  • Differentiate between real-world general facts and passage-supported assumptions.
  • Eliminate options that introduce completely unreferenced external topics such as cross-border dependencies.

Related facts for revision

  • Distinguishing Assumptions from Inferences in CSAT Reading Comprehension.
  • Identifying out-of-scope options that sound factually correct in general knowledge.
  • Main idea and policy trade-off identification techniques.
  • Using the elimination method for multi-statement comprehension questions.
How UPSC tests this

Ability to identify valid underlying assumptions while strictly adhering to text boundaries.

Trap: Candidates often select Statement 3 because affordable healthcare is a real-world policy goal, but it is not assumed or mentioned in the given text.

More Comprehension PYQs

All Comprehension questions →

Answer from the official UPSC answer key. Explanation by the EdiShorts editorial team.